Roche CDS Surge On Genentech Offer
Credit default swaps on Swiss pharmaceutical company Roche Holding soared to a record as investors expressed concern over the company’s hostile bid for Genentech.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts
